Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TOTAL LIABILITIES
Total Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
4.17 B
LAST VALUE
6.13%
2 YEAR CAGR
34.26%
5 YEAR CAGR
40.09%
10 YEAR CAGR